To our knowledge, this is the first study defining the functional requirement for NIK kinase activity in the context of OX40, TWEAK, BAFF, and CD40 signaling, and also the first description of NIK as a novel target for lupus. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.